ArticleCancers2026

Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting.

Onur Alkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.